R. Dupree

The 5‐HT1A/1B‐receptor agonist eltoprazine increases both catecholamine release in the prefrontal cortex and dopamine release in the nucleus accumbens and decreases motivation for reward and “waiting” impulsivity, but increases “stopping” impulsivity

O. Güntürkün, D. Denys, R. Oosting, 2017, European journal of pharmacology.